eMedicine Specialties > Gastroenterology > Biliary

Acalculous Cholecystopathy

Author: Alan BR Thomson, MD, MSc, PhD, Professor, Department of Medicine, Division of Gastroenterology, University of Alberta Faculty of Medicine
Coauthor(s): Walter E Pofahl, MD, Chief, Division of General Surgery, Associate Professor, Department of Surgery, Brody School of Medicine at East Carolina University; Jack A Di Palma, MD, Director, Division of Gastroenterology, Professor, Department of Internal Medicine, University of South Alabama College of Medicine
Contributor Information and Disclosures

Updated: Jun 12, 2008

Introduction

Background

The hallmark of acalculous cholecystopathy, frequently called biliary dyskinesia, is recurrent right upper quadrant pain in the absence of gallstones. Acalculous cholecystitis refers to cholecystitis without gallstones. Patients frequently undergo extensive, often invasive and expensive, testing prior to receiving definitive therapy. Although the treatment of choice is laparoscopic cholecystectomy, the rates of symptomatic improvement are not as favorable as in patients with biliary colic and gallstones.

Surgeons typically label acalculous cholecystopathy biliary dyskinesia. For gastroenterologists, biliary dyskinesia is a synonym for sphincter of Oddi dysfunction, which is a distinct disease process. This article discusses only acalculous cholecystopathy.

Pathophysiology

Acalculous cholecystopathy is a clinical condition characterized by biliary colic-type pain in the absence of gallstones. The exact pathophysiology is unknown but likely is due to an abnormal gallbladder motility that possibly causes a relative obstruction of the cystic duct.

Frequency

United States

The true incidence of acalculous cholecystopathy is unknown. With the advent of laparoscopic cholecystectomy, data suggesting an increased rate of cholecystectomy exist. In general, 10-15% of patients undergoing laparoscopic cholecystectomy have biliary dyskinesia.

International

No specific data on the incidence of biliary dyskinesia outside of the United States exist.

Mortality/Morbidity

The mortality and morbidity of acalculous cholecystopathy are related to the invasive diagnostic tests that frequently are performed and to the treatment of the condition (ie, cholecystectomy). Biliary dyskinesia does not progress to more serious conditions, such as acute cholecystitis.

Race

No data regarding racial distribution exist.

Sex

As with calculous biliary disease, acalculous cholecystopathy occurs more frequently in females than in males.

Age

As with calculous disease, most patients with acalculous cholecystopathy are aged 40-60 years.

Clinical

History

  • Pain  
    • Characteristically occurs in the right upper quadrant 30-60 minutes after meals
    • Usually lasts 1-4 hours and typically does not radiate
    • Often exacerbated by greasy and spicy foods
  • Nausea is the most commonly associated symptom.
  • Vomiting is unusual.
  • Other gastrointestinal symptoms suggest diagnoses other than acalculous cholecystopathy.
  • Acute cholecystitis may occur as a complication of critical illness, such as sepsis or cardiovascular disease.

Physical

  • The physical examination is directed toward ruling out other possible etiologies of the pain.
  • No abnormal physical examination findings usually are associated with acalculous cholecystopathy.
  • Mild right upper quadrant tenderness may occur.

Causes

  • A number of hormones have prokinetic or inhibitory effects on gallbladder motility.  
    • The hormones stimulating gallbladder contraction include cholecystokinin (CCK), gastrin, secretin, and motilin.
    • Vasoactive inhibitory peptide, somatostatin, and pancreatic polypeptide inhibit gallbladder motility.
    • Histamine stimulates contraction via histamine 1 (H1) receptors and relaxation via histamine 2 (H2) receptors.
    • Of these hormones, only somatostatin is used as a therapeutic agent. The actions of somatostatin appear to be due to the inhibition of CCK-mediated gallbladder emptying.
  • The increased incidence of calculous and acalculous biliary disease in females suggests an association with female sex hormones.  
    • Abnormalities in gallbladder emptying are especially pronounced during pregnancy.
    • Although estrogen and progesterone receptors have been found in the gallbladder, no direct effects of these hormones on gallbladder contractility have been elucidated.
  • The hepatic branches of the left vagus innervate the gallbladder. Division of these branches or of the anterior vagus during operations on the foregut is associated with an increased incidence of gallstones, presumably because of diminished gallbladder contractility. 
  • Cell proliferation and apoptosis may be increased in the gallbladder epithelium of patients with acute acalculous cholecystitis.

More on Acalculous Cholecystopathy

Overview: Acalculous Cholecystopathy
Differential Diagnoses & Workup: Acalculous Cholecystopathy
Treatment & Medication: Acalculous Cholecystopathy
Follow-up: Acalculous Cholecystopathy
Multimedia: Acalculous Cholecystopathy
References
[ CLOSE WINDOW ]

References

  1. Young SB, Arregui M, Singh K. HIDA scan ejection fraction does not predict sphincter of Oddi hypertension or clinical outcome in patients with suspected chronic acalculous cholecystitis. Surg Endosc. Dec 2006;20(12):1872-8. [Medline].

  2. Adams DB, Tarnasky PR, Hawes RH, Cunningham JT, Brooker C, Brothers TE, et al. Outcome after laparoscopic cholecystectomy for chronic acalculous cholecystitis. Am Surg. Jan 1998;64(1):1-5; discussion 5-6. [Medline].

  3. Ananian C, Dunn A, Mansourian V, Caride VJ. Scintigraphic gallbladder visualization with gangrenous acalculous cholecystitis. Clin Nucl Med. Nov 2006;31(11):701-3. [Medline].

  4. Canfield AJ, Hetz SP, Schriver JP, Servis HT, Hovenga TL, Cirangle PT, et al. Biliary dyskinesia: a study of more than 200 patients and review of the literature. J Gastrointest Surg. Sep-Oct 1998;2(5):443-8. [Medline].

  5. Fenster LF, Lonborg R, Thirlby RC, Traverso LW. What symptoms does cholecystectomy cure? Insights from an outcomes measurement project and review of the literature. Am J Surg. May 1995;169(5):533-8. [Medline].

  6. Gilliland TM, Traverso LW. Cholecystectomy provides long-term symptom relief in patients with acalculous gallbladders. Am J Surg. May 1990;159(5):489-92. [Medline].

  7. Goncalves RM, Harris JA, Rivera DE. Biliary dyskinesia: natural history and surgical results. Am Surg. Jun 1998;64(6):493-7; discussion 497-8. [Medline].

  8. Klieger PS, O'Mara RE. The clinical utility of quantitative cholescintigraphy: the significance of gallbladder dysfunction. Clin Nucl Med. May 1998;23(5):278-82. [Medline].

  9. Laurila J, Laurila PA, Saarnio J, Koivukangas V, Syrjala H, Ala-Kokko TI. Organ system dysfunction following open cholecystectomy for acute acalculous cholecystitis in critically ill patients. Acta Anaesthesiol Scand. Feb 2006;50(2):173-9. [Medline].

  10. Misra DC Jr, Blossom GB, Fink-Bennett D, Glover JL. Results of surgical therapy for biliary dyskinesia. Arch Surg. Aug 1991;126(8):957-60. [Medline].

  11. Nilsson E, Fored CM, Granath F, Blomqvist P. Cholecystectomy in Sweden 1987-99: a nationwide study of mortality and preoperative admissions. Scand J Gastroenterol. Dec 2005;40(12):1478-85. [Medline].

  12. Owen CC, Jain R. Acute Acalculous Cholecystitis. Curr Treat Options Gastroenterol. Apr 2005;8(2):99-104. [Medline].

  13. Passage J, Joshi P, Mullany DV. Acute cholecystitis complicating cardiac surgery: case series involving more than 16,000 patients. Ann Thorac Surg. Mar 2007;83(3):1096-101. [Medline].

  14. Ponsky TA, DeSagun R, Brody F. Surgical therapy for biliary dyskinesia: a meta-analysis and review of the literature. J Laparoendosc Adv Surg Tech A. Oct 2005;15(5):439-42. [Medline].

  15. Rastogi A, Slivka A, Moser AJ, Wald A. Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain. Dig Dis Sci. Aug 2005;50(8):1391-401. [Medline].

  16. Skipper K, Sligh S, Dunn E, Schwartz A. Laparoscopic cholecystectomy for an abnormal hepato-iminodiacetic acid scan: a worthwhile procedure. Am Surg. Jan 2000;66(1):30-2. [Medline].

  17. Sorenson MK, Fancher S, Lang NP, Eidt JF, Broadwater JR. Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesia. Am J Surg. Dec 1993;166(6):672-4; discussion 674-5. [Medline].

  18. Tierney S, Pitt HA, Lillemoe KD. Physiology and pathophysiology of gallbladder motility. Surg Clin North Am. Dec 1993;73(6):1267-90. [Medline].

  19. Vakkala M, Laurila JJ, Saarnio J, Koivukangas V, Syrjala H, Karttunen T, et al. Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis. Crit Care. 2007;11(5):R116. [Medline].

  20. Wald A. Functional biliary-type pain: update and controversies. J Clin Gastroenterol. May-Jun 2005;39(5 Suppl):S217-22. [Medline].

  21. Yost F, Margenthaler J, Presti M, Burton F, Murayama K. Cholecystectomy is an effective treatment for biliary dyskinesia. Am J Surg. Dec 1999;178(6):462-5. [Medline].

  22. Ziessman HA. Functional hepatobiliary disease: chronic acalculous gallbladder and chronic acalculous biliary disease. Semin Nucl Med. Apr 2006;36(2):119-32. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

biliary dyskinesia, acalculous cholecystitis, laparoscopic cholecystectomy, sphincter of Oddi dysfunction

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Alan BR Thomson, MD, MSc, PhD, Professor, Department of Medicine, Division of Gastroenterology, University of Alberta Faculty of Medicine
Alan BR Thomson, MD, MSc, PhD is a member of the following medical societies: American Federation for Aging Research, American Federation for Clinical Research, American Gastroenterological Association, American Geriatrics Society, American Physiological Society, Canadian Association of Gastroenterology, Gastroenterology Research Group, New York Academy of Sciences, and Royal Society of Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Walter E Pofahl, MD, Chief, Division of General Surgery, Associate Professor, Department of Surgery, Brody School of Medicine at East Carolina University
Walter E Pofahl, MD is a member of the following medical societies: American College of Surgeons, Association for Academic Surgery, Association for Surgical Education, Medical Association of the State of Alabama, Society of American Gastrointestinal and Endoscopic Surgeons, and Southeastern Surgical Congress
Disclosure: Nothing to disclose.

Jack A Di Palma, MD, Director, Division of Gastroenterology, Professor, Department of Internal Medicine, University of South Alabama College of Medicine
Jack A Di Palma, MD is a member of the following medical societies: American College of Gastroenterology and American Society for Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

Medical Editor

Marco G Patti, MD, Professor of Surgery, Director, Center for Esophageal Diseases, University of Chicago Pritzker School of Medicine
Marco G Patti, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Surgeons, American Gastroenterological Association, American Medical Association, American Surgical Association, Association for Academic Surgery, Pan-Pacific Surgical Association, Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons, Southwestern Surgical Congress, and Western Surgical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Michael A Grosso, MD, Consulting Staff, Department of Cardiothoracic Surgery, St Francis Hospital
Michael A Grosso, MD is a member of the following medical societies: American College of Surgeons, Society of Thoracic Surgeons, and Society of University Surgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other; AstraZeneca Grant/research funds Other

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.